Detalhe da pesquisa
1.
Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
Am J Kidney Dis
; 83(5): 588-600.e1, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38151224